Drugs / Diphtheria, Tetanus and Pertussis (DTaP)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04056117 | Sep 2019 → Sep 2022 | shigellosis | LimmaTech Biologics AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, Tetanus and Pertussis (DTaP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04056117 ↗ |
| Modality | Vaccine | “Control vaccine administrated to infants” NCT04056117 ↗ |